By Lauren Tanabe
Some experts view ketamine as a tool to unravel the biological causes of depression and, perhaps someday, cure it.
Read on elemental.medium.com
CLEAR ALL
The scientists hope their long-awaited study on LSD in humans will open the floodgates to further research into psychedelics.
1
In a recent UK trial, 12 patients with major depression took a pill quite different to commonly prescribed antidepressants: 25mg of psilocybin, the psychedelic compound found in magic mushrooms.
At Imperial College we’ve been comparing psilocybin to conventional antidepressants—and the results are likely to be game-changing.
A new brain-scan study helps explain how psilocybin works—and why it holds promise as a treatment for depression, addiction and post-traumatic stress.
How magic mushrooms expand consciousness.
2
This is an exciting time to be involved in psychedelic research. Medical researchers are rediscovering the possible benefits of responsible use of psychedelics in therapeutic settings.
The late chemist Albert Hofmann discussed his psychedelic research on LSD in the July, 1976 issue of High Times.